资讯 | 哔哩哔哩(BILI)获腾讯(0700)增持,股价收涨7.96%

wechat omage

美股

截至北京时间10月4日凌晨,美股周三收高,道指再创盘中与收盘历史最高纪录,银行板块领涨。美国ADP就业数据超出预期。意大利政府就预算问题向欧盟作出让步,降低了金融市场面临的风险。

截止收盘,道指涨54.45点,或0.2%,报26,828.39点;标普500指数涨2.08点,或0.07%,报2,925.51点;纳指涨25.54点,或0.32%,报8,025.08点。

周三盘中,道指最高上涨至26,951.81点,创盘中历史新高。银行股领涨大盘。

宏观基本面:

经济数据面,美国ADP就业机构报告称,美国9月ADP私营层面就业人数增加23万,预期18.4万,前值16.3万。

本周将公布三份有关美国劳动力市场的报告,ADP就业报告是其中的第一份。周四美国将公布上周首次申请失业救济数据。周五将公布备受关注的9月非农就业报告。

焦点股关注:

Facebook(FB)旗下的照片分享社交网络Instagram周三遭遇全球宕机,但此后已恢复为大多数用户提供服务。这是Instagram新主管刚刚上任几天后这款APP发生的故障。Facebook收高1.95%。

诺华制药(NVS)与波士顿制药公司(Boston Pharmaceuticals)签订了许可和股权协议,以开发三种抗感染药物候选药物。诺华制药收高1.29%。

哔哩哔哩:获腾讯增持,股价收涨7.96%

北京时间本周三,哔哩哔哩和腾讯联合宣布,双方已达成协议,腾讯将对哔哩哔哩(以下简称“B站”)进行共3.176亿美元现金的投资。

根据该协议,腾讯将以每股12.67美元的价格,认购B站新发行的普通股共计25,063,451股,价值约3.176亿美元。该交易预计将于近期完成。交易完成后,腾讯对B站持股比例将增至约12%。

哔哩哔哩股价盘前涨近15%,收涨约8%,盘中一度涨超16%,收盘上涨7.96%。

 

   

港股

北京时间10月3日,美股周二收盘涨跌不一。道指连续第二个交易日上涨,并创盘中与收盘历史新高。投资者仍在关注意大利预算案引发的恐慌以及国际贸易局势的进展。周三开盘,恒生指数低开1.05%,之后27000点附近反复拉。

截止收盘,恒生指数跌0.13%,报27091.26点,险守27000点。国企指数涨0.29%,报10786.17点;红筹指数涨0.05%,报4354.25点。大市成交674.52亿港元。

港股通方面,9月27日-10月7日均关闭,10月8日即星期一港股通开通。

沪、深港通方面,9月29日-10月7日关闭,10月8日正常开通。

焦点股关注:

濠赌股上涨,金沙中国涨2.64%,报34.95元;美高梅中国(2282)涨0.82%,报12.32元;银河娱乐(0027)涨1.48%,报48元;新濠国际涨2.08%,报15.68元。

燃气股上涨,中国燃气(0384)涨4.21%,报21.05元;新奥能源(2688)涨2.83%,报59.9元;新海能源(0342)涨1.63%,报2.49元。

恒大健康(0708)涨16.02%,报10.5元。日前,“中信信托·恒大南京恒康特定资产收益权投资集合资金信托计划”正式成立,拟募集资金20多亿元,用于投资恒大健康产业集团(以下简称“恒大健康”)旗下的南京恒大养生谷项目特定资产收益权,这是中信信托与恒大健康共同探索健康养生产业的新举措。

 

 

中国A股

中国市场周一至周五关闭,下周一正常开市。

 
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com